InvestorsHub Logo
Followers 0
Posts 118
Boards Moderated 0
Alias Born 02/24/2014

Re: None

Monday, 01/08/2018 11:53:54 AM

Monday, January 08, 2018 11:53:54 AM

Post# of 6315
They've been waiting for funding to apply and start trials for NB1111 (glaucoma) and NB1222 (CINV)...if Emerald can supply the funds, everything else is set up to get started. The glaucoma market for their NB1111 is $8B. Those are the announcements we need. No fluff, just funds to start the trials and get those trials going....then we move up. Tee'd up...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SKYE News